Large streamlined trials in cardiovascular disease

被引：21

作者：

Calvo, Gonzalo ^{[1
]}

McMurray, John J. V. ^{[2
]}

Granger, Christopher B. ^{[3
]}

Alonso-Garcia, Angeles ^{[4
]}

Armstrong, Paul ^{[5
]}

Flather, Marcus ^{[6
]}

Gomez-Outes, Antonio ^{[7
]}

Pocock, Stuart ^{[8
]}

Stockbridge, Norman ^{[9
]}

Svensson, Anders ^{[10
]}

Van de Werf, Frans ^{[11
]}

机构：

[1] Hosp Clin Barcelona, Inst Invest Agusti Pi & Sunyer IDIBAPS, Barcelona, Spain

[2] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland

[3] Duke Clin Res Inst, Durham, NC USA

[4] Univ London, Cardiovasc Sci Res Ctr, London WC1E 7HU, England

[5] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada

[6] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England

[7] Spanish Agcy Med & Med Devices AEMPS, Div Pharmacol & Clin Evaluat, Med Human Use, Madrid, Spain

[8] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England

[9] US FDA, Silver Spring, MD USA

[10] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

[11] Univ Leuven, Dept Cardiol, Louvain, Belgium

来源：

EUROPEAN HEART JOURNAL | 2014年 / 35卷 / 09期

关键词：

CLINICAL-TRIALS;

D O I：

10.1093/eurheartj/eht535

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：544 / 548

页数：5

共 16 条

[1] Documentation of study medication dispensing in a prospective large randomized clinical trial: Experiences from the ARISTOTLE Trial [J].

Alexander, John H. ;

Levy, Elliott ;

Lawrence, Jack ;

Hanna, Michael ;

Waclawski, Anthony P. ;

Wang, Junyuan ;

Califf, Robert M. ;

Wallentin, Lars ;

Granger, Christopher B. .

AMERICAN HEART JOURNAL, 2013, 166 (03) :559-+

[2] Time to move on from otime-to-first': should all events be included in the analysis of clinical trials? [J].

Anker, Stefan D. ;

McMurray, John J. V. .

EUROPEAN HEART JOURNAL, 2012, 33 (22) :2764-2765

[3] Evaluation of early percutaneous coronary intervention vs. standard therapy after fibrinolysis for ST-segment elevation myocardial infarction: contribution of weighting the composite endpoint [J].

Bakal, Jeffrey A. ;

Westerhout, Cynthia M. ;

Cantor, Warren J. ;

Fernandez-Aviles, Francisco ;

Welsh, Robert C. ;

Fitchett, David ;

Goodman, Shaun G. ;

Armstrong, Paul W. .

EUROPEAN HEART JOURNAL, 2013, 34 (12) :903-908

[4] Clinical trials bureaucracy: unintended consequences of well-intentioned policy [J].

Califf, Robert M. .

CLINICAL TRIALS, 2006, 3 (06) :496-502

[5] Characteristics of Clinical Trials Registered in ClinicalTrials.gov, 2007-2010 [J].

Califf, Robert M. ;

Zarin, Deborah A. ;

Kramer, Judith M. ;

Sherman, Rachel E. ;

Aberle, Laura H. ;

Tasneem, Asba .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (17) :1838-1847

[6] Sensible approaches for reducing clinical trial costs [J].

Eisenstein, Eric L. ;

Collins, Rory ;

Cracknell, Beena S. ;

Podesta, Oscar ;

Reid, Elizabeth D. ;

Sandercock, Peter ;

Shakhov, Yuriy ;

Terrin, Michael L. ;

Sellers, Mary Ann ;

Califf, Robert M. ;

Granger, Christopher B. ;

Diaz, Rafael .

CLINICAL TRIALS, 2008, 5 (01) :75-84

[7]

EMA, 2013, REFL PAP RISK BAS QU

[8]

EMA, 2013, GUID CLIN I IN PRESS

[9]

FDA, 2012, BRIEF DOC CARD REN D

[10]

FDA, 2013, GUID IND OV IN PRESS

← 1 2 →